Abbott Launches AI-Powered Coronary Imaging Platform in Europe

 Abbott Launches AI-Powered Coronary Imaging Platform in Europe

Abbott Receives CE Mark for Next-Generation Navitor TAVI System to Treat Aortic Stenosis

Shots:

  • Abbott’s new imaging platform powered by Ultreon 1.0 software has received a CE mark in the EU. The new imaging platform merges optical coherence tomography (OCT) with AI to enhance visualization and detect the severity of calcium-based blockages and measure vessel diameter
  • Ultreon software when integrated with Abbott’s new Dragonfly OpStar imaging catheter allows physicians to capture information from even more complex patient anatomy
  • The company plans to showcase the new Ultron software for the first time at the EuroPCR during the company’s “Tools and Technique Sessions’’ and plans to pursue regulatory approval in the US and Japan

Click here to­ read full press release/ article | Ref: Abbott | Image: Media Post

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post